Zydus Cadila receives tentative approval from USFDA for Ibrutinib
The drug will be manufactured at the group’s formulation manufacturing facility at the Special Economic Zone (SEZ), Ahmedabad
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ibrutinib tablets
NATCO gets tentative US FDA approval for Ibrutinib tablets
NATCO feels that it is eligible for 180 days of sole generic marketing exclusivity for all the strengths of the tablet dosage form…